全文获取类型
收费全文 | 5698篇 |
免费 | 307篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 39篇 |
儿科学 | 184篇 |
妇产科学 | 121篇 |
基础医学 | 732篇 |
口腔科学 | 143篇 |
临床医学 | 395篇 |
内科学 | 1138篇 |
皮肤病学 | 92篇 |
神经病学 | 413篇 |
特种医学 | 255篇 |
外科学 | 713篇 |
综合类 | 37篇 |
预防医学 | 614篇 |
眼科学 | 289篇 |
药学 | 420篇 |
中国医学 | 6篇 |
肿瘤学 | 445篇 |
出版年
2023年 | 28篇 |
2022年 | 62篇 |
2021年 | 124篇 |
2020年 | 64篇 |
2019年 | 105篇 |
2018年 | 121篇 |
2017年 | 99篇 |
2016年 | 85篇 |
2015年 | 126篇 |
2014年 | 136篇 |
2013年 | 169篇 |
2012年 | 300篇 |
2011年 | 304篇 |
2010年 | 163篇 |
2009年 | 139篇 |
2008年 | 289篇 |
2007年 | 289篇 |
2006年 | 317篇 |
2005年 | 311篇 |
2004年 | 322篇 |
2003年 | 291篇 |
2002年 | 282篇 |
2001年 | 225篇 |
2000年 | 191篇 |
1999年 | 169篇 |
1998年 | 67篇 |
1997年 | 54篇 |
1996年 | 72篇 |
1995年 | 35篇 |
1994年 | 31篇 |
1993年 | 21篇 |
1992年 | 100篇 |
1991年 | 80篇 |
1990年 | 77篇 |
1989年 | 83篇 |
1988年 | 99篇 |
1987年 | 62篇 |
1986年 | 64篇 |
1985年 | 60篇 |
1984年 | 55篇 |
1983年 | 29篇 |
1981年 | 17篇 |
1979年 | 25篇 |
1978年 | 30篇 |
1976年 | 21篇 |
1975年 | 21篇 |
1974年 | 22篇 |
1973年 | 34篇 |
1972年 | 18篇 |
1968年 | 18篇 |
排序方式: 共有6036条查询结果,搜索用时 0 毫秒
991.
992.
Mónica Viviana Alvarado-Mora Camila Malta Romano Michele Soares Gomes-Gouvêa Maria Fernanda Gutierrez Flair José Carrilho João Renato Rebello Pinho 《Infection, genetics and evolution》2011,11(6):1462-1468
Hepatitis delta virus (HDV) is widely distributed and associated with fulminant hepatitis epidemics in areas with high prevalence of HBV. Several studies performed in the 1980s showed data on HDV infection in South America, but there are no studies on the viral dynamics of this virus. The aim of this study was to conduct an evolutionary analysis of hepatitis delta genotype 3 (HDV/3) prevalent in South America: estimate its nucleotide substitution rate, determine the time of most recent ancestor (TMRCA) and characterize the epidemic history and evolutionary dynamics. Furthermore, we characterized the presence of HBV/HDV infection in seven samples collected from patients who died due to fulminant hepatitis from Amazon region in Colombia and included them in the evolutionary analysis. This is the first study reporting HBV and HDV sequences from the Amazon region of Colombia. Of the seven Colombian patients, five were positive for HBV-DNA and HDV-RNA. Of them, two samples were successfully sequenced for HBV (subgenotypes F3 and F1b) and the five samples HDV positive were classified as HDV/3. By using all HDV/3 available reference sequences with sampling dates (n = 36), we estimated the HDV/3 substitution rate in 1.07 × 10−3 substitutions per site per year (s/s/y), which resulted in a time to the most recent common ancestor (TMRCA) of 85 years. Also, it was determined that HDV/3 spread exponentially from early 1950s to the 1970s in South America. This work discusses for the first time the viral dynamics for the HDV/3 circulating in South America. We suggest that the measures implemented to control HBV transmission resulted in the control of HDV/3 spreading in South America, especially after the important raise in this infection associated with a huge mortality during the 1950s up to the 1970s. The differences found among HDV/3 and the other HDV genotypes concerning its diversity raises the hypothesis of a different origin and/or a different transmission route. 相似文献
993.
994.
995.
Marco Bernardi Anna Lucia Fedullo Elisabetta Bernardi Diego Munzi Ilaria Peluso Jonathan Myers Florigio Romano Lista Tommaso Sciarra 《World journal of gastroenterology : WJG》2020,26(20):2479-2497
The aim of this review is to offer dietary advice for individuals with spinal cord injury(SCI) and neurogenic bowel dysfunction. With this in mind, we consider health conditions that are dependent on the level of lesion including skeletal muscle atrophy, autonomic dysreflexia and neurogenic bladder. In addition, SCI is often associated with a sedentary lifestyle, which increases risk for osteoporosis and diseases associated with chronic low-grade inflammation, including cardiovascular and chronic kidney diseases. The Mediterranean diet, along with exercise and dietary supplements, has been suggested as an anti-inflammatory intervention in individuals with SCI. However, individuals with chronic SCI have a daily intake of whole fruit, vegetables and whole grains lower than the recommended dietary allowance for the general population. Some studies have reported an increase in neurogenic bowel dysfunction symptoms after high fiber intake; therefore, this finding could explain the low consumption of plant foods.Low consumption of fibre induces dysbiosis, which is associated with bothendotoxemia and inflammation. Dysbiosis can be reduced by exercise and diet in individuals with SCI. Therefore, to summarize our viewpoint, we developed a Mediterranean diet-based diet and exercise pyramid to integrate nutritional recommendations and exercise guidelines. Nutritional guidelines come from previously suggested recommendations for military veterans with disabilities and individuals with SCI, chronic kidney diseases, chronic pain and irritable bowel syndrome. We also considered the recent exercise guidelines and position stands for adults with SCI to improve muscle strength, flexibility and cardiorespiratory fitness and to obtain cardiometabolic benefits. Finally, dietary advice for Paralympic athletes is suggested. 相似文献
996.
Roberto Iacovelli Chiara Ciccarese Emilio Bria Mario Romano Emanuela Fantinel Davide Bimbatti Alessandro Muraglia Antonio Benito Porcaro Salvatore Siracusano Matteo Brunelli Renzo Mazzarotto Walter Artibani Giampaolo Tortora 《Clinical genitourinary cancer》2018,16(3):e645-e653
Introduction
The cardiovascular toxicity related to abiraterone and enzalutamide has been previously studied by our group. In this analysis, we aim to update our previous findings related to abiraterone and enzalutamide, including the new available evidence, both in castration-resistant and hormone-sensitive prostate cancer.Patients and Methods
Prospective studies were identified by searching the MEDLINE/PubMed, Cochrane Library, and ASCO Meeting abstracts. Combined relative risks (RRs) and 95% confidence intervals (CIs) were calculated using fixed- or random-effects methods.Results
We included 7 articles in this meta-analysis, covering a total of 8660 patients who were used to evaluate cardiovascular toxicity. The use of new hormonal agents was associated with an increased risk of all-grade (RR, 1.36; 95% CI, 1.13-1.64; P = .001) and high-grade (RR, 1.84; 95% CI, 1.21-2.80; P = .004) cardiac toxicity. The use of new hormonal agents was also associated with an increased risk of all-grade (RR, 1.98; 95% CI, 1.62-2.43; P = .001) and high-grade (RR, 2.26; 95% CI, 1.84-2.77; P = .004) hypertension compared with the controls. Abiraterone was found to significantly increase the risk of both cardiac toxicity and hypertension, whereas enzalutamide significantly increases only the risk of hypertension. No differences were found based on the dose of prednisone used with abiraterone. The major limitation of this study is that data are available only as aggregate, and no single-patient information could be analyzed.Conclusions
Abiraterone and enzalutamide significantly increase the incidence and RR of cardiovascular toxicity in patients affected by metastatic prostate cancer. Follow-up for the onset of treatment-related cardiovascular events should therefore be considered in these patients. 相似文献997.
Idalid Franco Yu-Hui Chen Fallon Chipidza Vishesh Agrawal John Romano Elizabeth Baldini Aileen Chen Yolonda Colson Ying Hou David Kozono Jon Wee Raymond Mak 《Journal of Geriatric Oncology》2018,9(2):130-137
Objectives
Frailty has been shown to increase morbidity and mortality independent of age, but studies are lacking in radiation oncology. This study evaluates a modified frailty index (mFI) in predicting overall survival (OS) and non-cancer death for Stage I/II [N0M0] Non-Small-Cell Lung Cancer (NSCLC) patients treated with Stereotactic Body Radiation Therapy (SBRT).Materials and Methods
Medical records for all patients with Stage I/II NSCLC treated at our institution with SBRT from 2009 to 2014 were reviewed. A validated mFI score, consisting of 11 variables was calculated, classifying patients as non-frail (0–1) or frail (≥ 2). Primary endpoint (OS) was analyzed using Kaplan-Meier method and log-rank. Secondary endpoint, non-cancer death, was analyzed using Fine-Gray's method, with death from lung cancer as a competing risk.Results
Patient cohort consisted of 38 (27.3%) non-frail and 101 (72.7%) frail [median total mFI score 3.0 (range 0–7)]. Median age and pack-year history was 74 and 46 years, respectively. Median follow-up among survivors was 38.5 months (range 4.0–74.1 months). Frailty was associated with a lower 3-year OS (37.3% vs. 74.7%; p = 0.003) and 3-year cumulative incidence of non-cancer death (36.7% vs. 12.5%; p = 0.02). Frailty remained significant in the multivariate model [OS HR for mFI ≥ 2: 2.25 (1.14–4.44); p = 0.02].Conclusion
Frailty is associated with lower OS in older patients with early stage NSCLC treated with SBRT, yet frail patients survived a median 2.5 years, and were more likely to die of causes unrelated to the primary lung cancer, suggesting SBRT should be considered even in older patients deemed unfit for surgery. 相似文献998.
999.
Romano Demicheli Monica Terenziani Gianni Bonadonna 《Breast cancer research and treatment》1998,51(2):133-137
To obtain an estimate of the subclinical tumor growth time (TGT) for breast cancer, a series of 31 patients with local recurrence as first event after mastectomy was evaluated. The recurrence diameter was measured, and the minimum growth rate (mGR) consistent with the sequence no detection at the preceding physical examination recurrence of diameter Dr was obtained. The growth rate for uninterrupted exponential growth from surgery (GRu) was also calculated. mGR was significantly higher than GRu (p < 0.0001), and unrelated to the recurrence-free survival (RFS). Therefore, starting points of local recurrence growth curves had to be set at times variously delayed after mastectomy. The estimate of the delay lower limit (mD), which was obtained from mGR and GRu, showed a strong linear correlation with RFS (R=0.984; p < 0.0001). From the regression equation, TGT for local recurrences could be estimated at 30 ± 8 weeks or less. These findings support the concept that the lag time between surgical treatment of breast cancer and clinical evidence of local recurrence may be explained by a period of tumor dormancy followed by a tumor growing phase. The TGT estimate is remarkably shorter than previously believed and could considerably change the current picture of breast cancer history. 相似文献
1000.